Gainers
-
Novocure Ltd (NASDAQ: NVCR) shares rose 23.5
percent to $9.99 in pre-market trading. Novocure announced that the long-term survival analysis of all 695 patients enrolled in
its phase 3 pivotal EF-14 trial in newly diagnosed glioblastoma confirms superior progression free and overall survival seen in
the trial’s interim Analysis.
-
Raptor Pharmaceutical Corp. (NASDAQ: RPTP) rose
20 percent to $8.94 in pre-market trading after Horizon Pharma plc (NASDAQ: HZNP) agreed to acquire Raptor Pharmaceutical for $9 per share in cash.
-
Novavax, Inc. (NASDAQ: NVAX) shares rose 2.7
percent to $8.00 in pre-market trading after gaining 3.87 percent on Friday.
-
Foamix Pharmaceuticals Ltd (NASDAQ: FOMX) shares
rose 2.4 percent to $9.00 in pre-market trading as the company disclosed that it has met primary and secondary endpoints in
Phase 2 FMX103 study.
-
SolarCity Corp (NASDAQ: SCTY) rose 1.7 percent to
$17.05 in the pre-market trading session after declining 3.84 percent on Friday.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
-
Geron Corporation (NASDAQ: GERN) shares fell 27.6
percent to $2.07 in pre-market trading after the company issued an update on imetelstat trials being conducted by Janssen
Research & Development, LLC.
-
Amarin Corporation plc (ADR) (NASDAQ: AMRN)
shares fell 12 percent to $2.79 in pre-market trading as the company disclosed that its REDUCE-IT cardiovascular outcomes study
of Vascepa will continue as planned at recommendation of the independent data monitoring committee.
-
Momo Inc (ADR) (NASDAQ: MOMO) fell 6.2 percent to
$20.32 after declining 11.48 percent on Friday.
-
TrueCar Inc (NASDAQ: TRUE) shares fell 4.6
percent to $8.42 in pre-market trading. Morgan Stanley downgraded TrueCar from Equal-weight to Underweight
-
SINA Corp (NASDAQ: SINA) shares fell 4.2 percent
to $71.98 in pre-market trading after dropping 2.57 percent on Friday.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.